FEDERAL · 21 U.S.C. · Chapter 9

Serious adverse event reporting for dietary supplements

Current through Pub. L. 119-102
Title 21Food and Drugs·Ch. 9 — FEDERAL FOOD, DRUG, AND COSMETIC ACT·Subch. VII·Pt. H
(a)Definitions In this section:
(1)Adverse event The term "adverse event" means any health-related event associated with the use of a dietary supplement that is adverse.
(2)Serious adverse event The term "serious adverse event" is an adverse event that—
(A)results in—
(i)death;
(ii)a life-threatening experience;
(iii)inpatient hospitalization;
(iv)a persistent or significant disability or incapacity; or
(v)a congenital anomaly or birth defect; or
(B)requires, based on reasonable medical judgment, a medical or surgical intervention to prevent an outcome described under subparagraph (A).
(3)Serious adverse event report The term "serious adverse event report" means a report that is required to be submitted to the Secretary under subsection (b).
(b)Reporting requirement
(1)In gene

Free access — add to your briefcase to read the full text and ask questions with AI

21 U.S.C. § 379aa–1 (Serious adverse event reporting for dietary supplements) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 343
21 U.S.C. § 343
§ 374
21 U.S.C. § 374
§ 379v
21 U.S.C. § 379v
§ 552a
5 U.S.C. § 552a
§ 552
21 U.S.C. § 552

Source Credit

History

(June 25, 1938, ch. 675, §761, as added Pub. L. 109–462, §3(a), Dec. 22, 2006, 120 Stat. 3472.)

Editorial Notes

Statutory Notes and Related Subsidiaries

Effective Date
Section effective 1 year after Dec. 22, 2006, see section 3(d)(1) of Pub. L. 109–462, set out as an Effective Date of 2006 Amendment note under section 343 of this title.